These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21009567)

  • 21. [Effect of temperature on the statics and kinetics of cellular penetration of urea, thiourea and sulfanilamide].
    LINDENBERG AB; MASSIN M
    J Physiol (Paris); 1956; 48(3):616-8. PubMed ID: 13346578
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of vitamin B1 on conversion of sulfanilamides in the animal organism].
    KAGAN IuS
    Vopr Fiziol; 1953; 6():126-31. PubMed ID: 13226776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary study on sulfanilamide metabolism].
    BOYER F; SAVIARD M; DECHAVASSINE M
    C R Hebd Seances Acad Sci; 1955 May; 240(20):2023-4. PubMed ID: 14390786
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative activity of depot sulfanilamides in experimental infection in mice caused by K1. pneumoniae].
    Padeĭskaia EN; Kutchak SN; Polukhina LM
    Antibiotiki; 1980 Mar; 25(3):193-8. PubMed ID: 6987948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adsorption of sulfanilic acid, sulfanilamide and sulfaethylthiodiazole on plasma proteins and their influence on distribution processes. V. Dynamics of distribution].
    LANGECKER H; LOPPNOW H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 226(1):36-45. PubMed ID: 13253691
    [No Abstract]   [Full Text] [Related]  

  • 26. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 5-SUBSTITUED 4-THIAZOLIDINONES WITH SULFANILAMIDE PHARMACOPHORE.
    Zevzikoviene A; Zevzikovas A; Lukosius A; Tarasevicius E
    Acta Pol Pharm; 2016 Sep; 73(5):1155-1161. PubMed ID: 29638056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the toxicity of sulfonamide drugs porphyrin excretion by a patient treated with sulfadiazine and later with sulfanilamide.
    FIGGE FH; CAREY TN; WEILAND GS
    J Lab Clin Med; 1946 Jul; 31(7):752-6. PubMed ID: 20992877
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the solubility of sulfanilamide preparations. V. Solubility of sulfanilamides in phosphato-citric buffer preparations].
    Golovkin VA
    Farm Zh; 1965; 20(5):44-50. PubMed ID: 5888686
    [No Abstract]   [Full Text] [Related]  

  • 29. [A NEW METHOD FOR DETERMINING THE RATE CONSTANT OF ABSORPTION AND DISTRIBUTION].
    DILLER W
    Antibiot Chemother; 1964; 12():85-94. PubMed ID: 14262408
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE USE OF SULFANILAMIDES COMBINED WITH ANTIBIOTICS AND ON THE ADVANTAGE OF SULFAPYRIDAZINE--A SULFANILAMIDE OF PROLONGED ACTION].
    GOVOROVICH IeA; MARSHAK AM
    Sov Med; 1963 Oct; 27():19-25. PubMed ID: 14131699
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of deamination reactions by Escherichia coli in the presence of sulfanilamide alone and associated with phenol].
    KAYSER F; POUTEAU-THOUVENOT M; PREVOT AR
    Bull Soc Chim Biol (Paris); 1951; 33(11-12):1731-9. PubMed ID: 14935692
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the delay in the bacteriostatic action of sulfanilamide on Escherichia coli.
    YOUMANS AS
    J Bacteriol; 1947 Jul; 54(1):5. PubMed ID: 20344224
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sulfanilamide inhibition of bicarbonate reabsorption in the human kidney].
    OCHWADT B
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1950; 211(4):321-7. PubMed ID: 14790713
    [No Abstract]   [Full Text] [Related]  

  • 34. [6-Mercaptopurine inhibition of the acetylation of sulfanilamide in vivo].
    GARATTINI S; PAOLETTI R
    G Ital Chemioter; 1956; 3(1-2):55-7. PubMed ID: 13365998
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of biologic acetylation by 1-hydrazinophthalazine.
    DOUGLASS CD; DILLAHA CJ; DILLAHA J; KOUNTZ SL
    J Lab Clin Med; 1957 Apr; 49(4):561-5. PubMed ID: 13406391
    [No Abstract]   [Full Text] [Related]  

  • 36. [State of the hemato-encephalic barrier in sulfanilamide therapy].
    STARICYN SE
    Biull Eksp Biol Med; 1947; 23(3):221-3. PubMed ID: 18858152
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary and fecal excretion of sulfanilamide derivatives after oral administration to rats.
    TAYLOR E; SNYDER FH; OBERST FW
    J Pharmacol Exp Ther; 1947 Jun; 90(2):154-60. PubMed ID: 20249076
    [No Abstract]   [Full Text] [Related]  

  • 38. INHIBITION OF D-PANTOTHENATE BY L-PANTOTHENATE IN THE RAT.
    Sarett HP; Barboriak JJ
    Am J Clin Nutr; 1963 Dec; 13():378-84. PubMed ID: 14101399
    [No Abstract]   [Full Text] [Related]  

  • 39. [Separation and determination of mixtures of 8-quinolinol sulfate and sulfanilamide].
    BONTEMPS R
    J Pharm Belg; 1952; 7(11-12):553-6. PubMed ID: 13045201
    [No Abstract]   [Full Text] [Related]  

  • 40. The excretion of sulfanilamide derivatives after oral administration to white rats.
    TAYLOR E; SNYDER FH; OBERST FW
    Fed Proc; 1947; 6(1):297. PubMed ID: 20343618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.